
Looking to sell Marea stock or options?
Marea is a biotechnology company focused on cardiometabolic diseases. Its primary initiative, MAR001, is currently in Phase 2 of clinical development. Marea is dedicated to creating innovative treatments for individuals at risk of heart attacks, aiming to address elevated remnant cholesterol and metabolic dysfunction.
Third Rock Ventures, Perceptive Advisors, Forbion, Alpha Wave Global, Sofinnova Investments, Surveyor Capital, venBio, Omega Funds, Perceptive Xontogeny Venture Fund.